Clinical Trial Update: Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This update indicates a Phase 1/2 clinical trial is recruiting to evaluate mesenchymal stromal cells for treating digital ulcers in systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digital Ulcers
• Systemic Sclerosis

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: UMC Utrecht | Conditions: Systemic Sclerosis, Digital Ulcer | Phase 1, Phase 2 | Status: RECRUITING